Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 3 days · First seen 18 days ago · Last updated 15 days ago

Canadian cannabis firms financial growth

Overview

In early August 2026, Cronos Group reported a record second‑quarter net revenue of $53 million, driven by higher cannabis flower sales in Israel and Germany, while Aurora Cannabis posted strong first‑quarter 2027 results with international medical cannabis sales up 17% year‑over‑year, largely from Germany. Both companies highlighted expanding overseas revenue, with Aurora noting that about 64% of its revenue now comes from outside Canada.

Two days later, Aurora Cannabis announced that its fiscal 2026 revenue beat expectations, reaching C$321 million, an 11% increase year‑over‑year, and that roughly 55% of that revenue was generated abroad. The company also reported improved gross margins and EBITDA, and its shareholders reappointed a five‑director board and retained Ernst & Young as auditor. These developments show continued financial momentum for Canada’s leading cannabis producers, underscored by growing international market exposure and solid corporate governance actions.

Entities

Aurora Cannabis Inc. · Cronos Group Inc. · Germany · Ernst & Young LLP · Israel

Timeline

15 days ago

[BUSINESS] 2 sources
Aurora Cannabis posts fiscal 2026 revenue beat, reappoints board
Aurora Cannabis' virtual AGM approved a five‑member board, reappointed Ernst & Young, and reported fiscal 2026 revenue of C$321 million, an 11% rise, with earnings above guidance.
18 days ago

[BUSINESS] 3 sources
Canadian cannabis firms Cronos Group and Aurora post record earnings
Cronos Group posted record Q2 revenue of $53 M and net income of $35.7 M, driven by growth in Israel and Germany, while Aurora Cannabis reported Q1 revenue of C$67.6 M with 64% from abroad, highlighting strong

Sources

pressreach.com · seekingalpha.com · stocknews.com · themarijuanaherald.com